Skip to main content
Clinical Trials/NCT04443205
NCT04443205
Unknown
Not Applicable

Relevance of Ultrasound Screening for Foetal Macrosomia and Description of Its Management in Champagne-Ardenne

CHU de Reims1 site in 1 country3,000 target enrollmentJune 2020
ConditionsPregnancy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy
Sponsor
CHU de Reims
Enrollment
3000
Locations
1
Primary Endpoint
Foetal macrosomia
Last Updated
5 years ago

Overview

Brief Summary

Management of fetal macrosomia is based on a suspicion of macrosomia (no certainty before birth). This management is an artificial induction of labour for an earlier delivery and therefore a lower fetal weight gain. Several studies have already shown that ultrasound performed during the third trimester of pregnancy was not a perfect tool for this screening.

Detailed Description

The aim of the study is to describe management of women whose child is macrosomal but has not been screened g using ultrasound during the third trimester of pregnancy.

Registry
clinicaltrials.gov
Start Date
June 2020
End Date
December 2021
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Foetal macrosomia

Time Frame: Baseline

estimated weight above the 90th percentile of the curves of the French College of Fetal Ultrasound during the third trimester ultrasound

Study Sites (1)

Loading locations...

Similar Trials